Skip to main content
Report File
Date Issued
Submitting OIG
Department of Labor OIG
Other Participating OIGs
Department of Labor OIG
Agencies Reviewed/Investigated
Department of Labor
Report Number
03-23-001-04-431
Report Type
Audit
Agency Wide
Yes
Number of Recommendations
10
Questioned Costs
$0
Funds for Better Use
$0
Additional Details
https://www.oig.dol.gov/public/reports/oa/2023/03-23-001-04-431.pdf

Open Recommendations

This report has 3 open recommendations.
Recommendation Number Significant Recommendation Recommended Questioned Costs Recommended Funds for Better Use Additional Details
1 Yes $0 $321,261,486

We recommend the Director of OWCP implement a process to ensure competitive prices for the FECA program by regularly evaluating alternate pricing methodologies and other sources — including state fee schedules, ACA FUL, NADAC, MAC lists, market research, and comparable payers — and updating its pricing methodology as appropriate.

2 Yes $0 $0

We recommend the Director of OWCP implement a process to collect drug manufacturer rebates.

6 Yes $0 $0

We recommend the Director of OWCP implement a technology solution to perform ongoing prescription claim level reviews in near real-time - including contractual adherence by the PBM, prescription drug pricing discounts, and rebate guarantees - as well as to validate prescription drug pricing methodology.

Department of Labor OIG

United States